Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2026-05-19 @ 8:07 AM
Study NCT ID:
NCT01660360
Status:
COMPLETED
Last Update Posted:
2014-01-29
First Post:
2012-08-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Trial of Tanibirumab in Advanced or Metastatic Cancer
Sponsor:
PharmAbcine
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PMC1101-TAAC01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None